ZLAB News and Press, Zai Lab Limited From 12/27/23

2023-12-27 14:59:02 ET More on NovoCure NovoCure: Significant Upside Even Without A Breakthrough NovoCure Limited 2023 Q3 - Results - Earnings Call Presentation NovoCure Limited (NVCR) Q3 2023 Earnings Call Transcript Novocure to eliminate 13% of workforce in...

2023-12-21 08:16:36 ET Losers: Polished.com ( POL ) -36% . Dune Acquisition Corporation ( DUNE ) -17% . Panbela Therapeutics ( PBLA ) -10% . Applied UV ( AUVI ) -9% . Tantech Holdings Ltd ( TANH ) -9% . Longeveron ( LGVN ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that members of the Company’s senior management team will participate in the following investor conference in January 2024: J.P. Morgan 42nd Annual Healthcare Conference Presentation: Monday, January 8, 2024, 3:45 p.m. PS...

BOSTON, Dec. 13, 2023 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of innovative therapies for life-threatening diseases and other public health threats, today announced that China’s National Healt...

2023-12-13 08:23:33 ET More on Zai Lab Zai Lab: Strong Growth Amidst Strategic Shifts (Rating Upgrade) Zai Lab Limited (ZLAB) Q3 2023 Earnings Call Transcript Zai Lab Q3 2023 Earnings Preview Seagen, Genmab update Phase 3 data for uterine cancer therapy ...

Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that the 2023 National Reimbursement Drug List (NRDL) released by China’s National Healthcare Security Administration (NHSA) has been updated to include the following medicines and indications: VYVGART ® (efgarti...

2023-11-28 06:45:51 ET More on Argenx, Halozyme, etc. argenx Q3: Navigating The Highs And Hurdles Of A Market Odyssey (Rating Upgrade) Halozyme Q3: Navigating The Ups And Downs Of Its Innovative Pathway Halozyme Therapeutics, Inc. (HALO) Q3 2023 Earnings Call Transcr...

2023-11-19 11:16:04 ET Summary Zai Lab shows strong growth in oncology/autoimmune drugs; reduced losses and efficient operations evident in Q3 results. Healthy financial status with a strong current ratio of 7.68; reduced R&D expenses might signal efficiency or underinvestment...

2023-11-17 10:55:23 ET More on Zai Lab Zai Lab Stock: De-Risking Through Market Tapping Zai Lab Q3 2023 Earnings Preview Seagen, Genmab update Phase 3 data for uterine cancer therapy Seeking Alpha’s Quant Rating on Zai Lab For further details s...

2023-11-08 14:00:22 ET Zai Lab Limited (ZLAB) Q3 2023 Earnings Conference Call November 08, 2023 08:00 AM ET Company Participants Christine Chiou - Senior Vice President-Investor Relations Samantha Du - Founder, Chairperson & Chief Executive Officer Josh Smil...